Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Review of Brazil's HIV/AIDS Treatment Programs Shows Importance of Generic Drugs, Researchers Say

July 15, 2009

"Brazil has been successful in its nearly 20-year effort to treat people living with" HIV/AIDS, and generic medicines have been "a large part of the solution," according to a recent Health Affairs review, UPI reports (UPI, 7/14). The review examines Brazil's passing of "a law in the 1990s that guaranteed citizens free and universal access to drugs for HIV and AIDS treatment" as well as the country's production of generic HIV/AIDS medicines in public factories, AHN reports. "The [Brazilian] government also prompted drug companies to lower their prices by threatening to make generic versions of [patented] HIV and AIDS drugs in the public factories," writes AHN (Goodhue, 7/14).

"Brazil has proved it is possible to treat people with AIDS in developing countries," said lead author Amy Nunn, an assistant professor at Brown University, in a written statement. "[T]he country saved more than $1 billion as a result of bargaining with multinational pharmaceutical companies, resulting in significant changes in global AIDS policy," according to a Brown University/EurekAlert! release (7/14).

"Although Brazil's exact model might not be replicated elsewhere, it provides evidence that AIDS treatment is possible in a developing country," the authors write, adding, "Other countries, particularly middle-income countries, have learned much from Brazil?s experience as they now negotiate deep discounts with pharmaceutical companies, benefit from tiered pricing structures, issue compulsory licenses, rely increasingly on generics, work with blossoming civil-society movements, implement new health infrastructure, and provide millions of people with AIDS treatment" (Nunn et. al, Health Affairs, 7/09).

Back to other news for July 2009

Advertisement


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on Generic/Discount HIV Drug Access in the Developing World

Tools
 

Advertisement